APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Efavirenz

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Efavirenz Industry Growth and Trends Forecast to 2032

Report ID 173987420122 December 202590 pages

Choose your research edition.

Industry ResearchEfavirenz Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Efavirenz Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Efavirenz Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Efavirenz Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Efavirenz Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Efavirenz market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Efavirenz is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Efavirenz is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Efavirenz is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Efavirenz include Teva, Mylan, Macleods Pharmaceuticals, Hetero, Cipla, Bristol-Myers Squibb and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Efavirenz market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Efavirenz market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Efavirenz market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Efavirenz.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Efavirenz market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Efavirenz Market by Company

Teva

Mylan

Macleods Pharmaceuticals

Hetero

Cipla

Bristol-Myers Squibb

Aurobindo Pharma

Efavirenz Segment by Type

Two-drug combination

Three-drug combination

Efavirenz Segment by Application

Adults

Children

Efavirenz Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Efavirenz and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Efavirenz manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Efavirenz in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Two-drug combination Table 2. Major Company of Three-drug combination Table 3. Global Efavirenz Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Efavirenz Sales by Type (2021-2026) & (k units) Table 5. Global Efavirenz Sales Market Share in Volume by Type (2021-2026) Table 6. Global Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 7. Global Efavirenz Sales Market Share in Value by Type (2021-2026) Table 8. Global Efavirenz Price by Type (2021-2026) & (US$/unit) Table 9. Global Efavirenz Sales by Type (2027-2032) & (k units) Table 10. Global Efavirenz Sales Market Share in Volume by Type (2027-2032) Table 11. Global Efavirenz Sales by Type (2027-2032) & (US$ Million) Table 12. Global Efavirenz Sales Market Share in Value by Type (2027-2032) Table 13. Global Efavirenz Price by Type (2027-2032) & (US$/unit) Table 14. North America Efavirenz Sales by Type (2021-2026) & (k units) Table 15. North America Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Efavirenz Sales by Type (2021-2026) & (k units) Table 17. Europe Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Efavirenz Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Efavirenz Sales by Type (2021-2026) & (k units) Table 21. Latin America Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Efavirenz Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Efavirenz Sales by Type (2021-2026) & (US$ Million) Table 24. Efavirenz Industry Trends Table 25. Efavirenz Industry Drivers Table 26. Efavirenz Industry Opportunities and Challenges Table 27. Efavirenz Industry Restraints Table 28. Global Efavirenz Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Efavirenz Revenue Market Share by Company (2021-2026) Table 30. Global Efavirenz Sales by Company (2021-2026) & (k units) Table 31. Global Efavirenz Sales Share by Company (2021-2026) Table 32. Global Efavirenz Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Efavirenz Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Efavirenz Major Company Production Sites and Headquarters Table 35. Global Efavirenz Company, Product Type & Application Table 36. Global Efavirenz Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Efavirenz by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Efavirenz Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Efavirenz Sales by Region (2021-2026) & (k units) Table 41. Global Efavirenz Sales Market Share in Volume by Region (2021-2026) Table 42. Global Efavirenz Sales by Region (2021-2026) & (US$ Million) Table 43. Global Efavirenz Sales Market Share in Value by Region (2021-2026) Table 44. Global Efavirenz Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Efavirenz Sales by Region (2027-2032) & (k units) Table 46. Global Efavirenz Sales Market Share in Volume by Region (2027-2032) Table 47. Global Efavirenz Sales by Region (2027-2032) & (US$ Million) Table 48. Global Efavirenz Sales Market Share in Value by Region (2027-2032) Table 49. Global Efavirenz Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Efavirenz Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Efavirenz Sales by Application (2021-2026) & (k units) Table 52. Global Efavirenz Sales Market Share in Volume by Application (2021-2026) Table 53. Global Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 54. Global Efavirenz Sales Market Share in Value by Application (2021-2026) Table 55. Global Efavirenz Price by Application (2021-2026) & (US$/unit) Table 56. Global Efavirenz Sales by Application (2027-2032) & (k units) Table 57. Global Efavirenz Sales Market Share in Volume by Application (2027-2032) Table 58. Global Efavirenz Sales by Application (2027-2032) & (US$ Million) Table 59. Global Efavirenz Sales Market Share in Value by Application (2027-2032) Table 60. Global Efavirenz Price by Application (2027-2032) & (US$/unit) Table 61. North America Efavirenz Sales by Application (2021-2026) & (k units) Table 62. North America Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Efavirenz Sales by Application (2021-2026) & (k units) Table 64. Europe Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Efavirenz Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Efavirenz Sales by Application (2021-2026) & (k units) Table 68. Latin America Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Efavirenz Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Efavirenz Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Efavirenz Product Portfolio Table 75. Teva Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Mylan Efavirenz Product Portfolio Table 80. Mylan Recent Development Table 81. Macleods Pharmaceuticals Company Information Table 82. Macleods Pharmaceuticals Business Overview Table 83. Macleods Pharmaceuticals Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Macleods Pharmaceuticals Efavirenz Product Portfolio Table 85. Macleods Pharmaceuticals Recent Development Table 86. Hetero Company Information Table 87. Hetero Business Overview Table 88. Hetero Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hetero Efavirenz Product Portfolio Table 90. Hetero Recent Development Table 91. Cipla Company Information Table 92. Cipla Business Overview Table 93. Cipla Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Cipla Efavirenz Product Portfolio Table 95. Cipla Recent Development Table 96. Bristol-Myers Squibb Company Information Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bristol-Myers Squibb Efavirenz Product Portfolio Table 100. Bristol-Myers Squibb Recent Development Table 101. Aurobindo Pharma Company Information Table 102. Aurobindo Pharma Business Overview Table 103. Aurobindo Pharma Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Aurobindo Pharma Efavirenz Product Portfolio Table 105. Aurobindo Pharma Recent Development Table 106. North America Efavirenz Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Efavirenz Sales by Country (2021-2026) & (k units) Table 108. North America Efavirenz Sales Market Share by Country (2021-2026) Table 109. North America Efavirenz Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Efavirenz Sales Market Share Forecast by Country (2027-2032) Table 111. North America Efavirenz Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Efavirenz Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Efavirenz Market Share by Country (2021-2026) Table 114. North America Efavirenz Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Efavirenz Market Share Forecast by Country (2027-2032) Table 116. Europe Efavirenz Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Efavirenz Sales by Country (2021-2026) & (k units) Table 118. Europe Efavirenz Sales Market Share by Country (2021-2026) Table 119. Europe Efavirenz Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Efavirenz Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Efavirenz Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Efavirenz Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Efavirenz Market Share by Country (2021-2026) Table 124. Europe Efavirenz Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Efavirenz Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Efavirenz Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Efavirenz Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Efavirenz Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Efavirenz Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Efavirenz Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Efavirenz Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Efavirenz Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Efavirenz Market Share by Country (2021-2026) Table 134. Asia-Pacific Efavirenz Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Efavirenz Market Share Forecast by Country (2027-2032) Table 136. Latin America Efavirenz Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Efavirenz Sales by Country (2021-2026) & (k units) Table 138. Latin America Efavirenz Sales Market Share by Country (2021-2026) Table 139. Latin America Efavirenz Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Efavirenz Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Efavirenz Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Efavirenz Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Efavirenz Market Share by Country (2021-2026) Table 144. Latin America Efavirenz Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Efavirenz Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Efavirenz Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Efavirenz Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Efavirenz Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Efavirenz Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Efavirenz Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Efavirenz Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Efavirenz Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Efavirenz Market Share by Country (2021-2026) Table 154. Middle East and Africa Efavirenz Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Efavirenz Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Efavirenz Distributors List Table 159. Efavirenz Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Efavirenz Image Figure 2. Global Efavirenz Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Efavirenz Market Size (2021-2032) & (US$ Million) Figure 4. Global Efavirenz Sales (2021-2032) & (k units) Figure 5. Two-drug combination Image Figure 6. Global Two-drug combination Sales YoY Growth (2021-2032) & (k units) Figure 7. Three-drug combination Image Figure 8. Global Three-drug combination Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Efavirenz Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Efavirenz Market Share by Type 2025 VS 2032 Figure 11. North America Efavirenz Sales Market Share in Volume by Type in 2025 Figure 12. North America Efavirenz Sales Market Share in Value by Type in 2025 Figure 13. Europe Efavirenz Sales Market Share in Volume by Type in 2025 Figure 14. Europe Efavirenz Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Efavirenz Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Efavirenz Sales Market Share in Value by Type in 2025 Figure 17. Latin America Efavirenz Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Efavirenz Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Efavirenz Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Efavirenz Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Efavirenz Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adults Image Figure 24. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Efavirenz Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Efavirenz Market Share by Application 2025 VS 2032 Figure 29. North America Efavirenz Sales Market Share in Volume by Application in 2025 Figure 30. North America Efavirenz Sales Market Share in Value by Application in 2025 Figure 31. Europe Efavirenz Sales Market Share in Volume by Application in 2025 Figure 32. Europe Efavirenz Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Efavirenz Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Efavirenz Sales Market Share in Value by Application in 2025 Figure 35. Latin America Efavirenz Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Efavirenz Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Efavirenz Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Efavirenz Sales Market Share in Value by Application in 2025 Figure 39. North America Efavirenz Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Efavirenz Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Efavirenz Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Efavirenz Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Efavirenz Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Efavirenz Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Efavirenz Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Efavirenz Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Efavirenz Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Efavirenz Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Efavirenz Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Efavirenz Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Efavirenz Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Efavirenz Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Efavirenz Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Efavirenz Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Efavirenz Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Efavirenz Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Efavirenz Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Efavirenz Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Efavirenz Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Efavirenz Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Two-drug combination
  • Three-drug combination
Applications
  • Adults
  • Children
Companies covered
  • Teva
  • Mylan
  • Macleods Pharmaceuticals
  • Hetero
  • Cipla
  • Bristol-Myers Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Efavirenz Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Efavirenz Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Efavirenz Market by Type
  6. 1.3.1 Two-drug combination
  7. 1.3.2 Three-drug combination
  8. 1.4 Global Efavirenz Market Size by Type
  9. 1.4.1 Global Efavirenz Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Efavirenz Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Efavirenz Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Efavirenz Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Efavirenz Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Efavirenz Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Efavirenz Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Efavirenz Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Efavirenz Industry Trends
  2. 2.2 Efavirenz Industry Drivers
  3. 2.3 Efavirenz Industry Opportunities and Challenges
  4. 2.4 Efavirenz Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Efavirenz Revenue (2021-2026)
  2. 3.2 Global Top Players by Efavirenz Sales (2021-2026)
  3. 3.3 Global Top Players by Efavirenz Price (2021-2026)
  4. 3.4 Global Efavirenz Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Efavirenz Major Company Production Sites & Headquarters
  6. 3.6 Global Efavirenz Company, Product Type & Application
  7. 3.7 Global Efavirenz Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Efavirenz Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Efavirenz Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Efavirenz Tier 1, Tier 2, and Tier 3
4 Efavirenz Regional Status and Outlook
  1. 4.1 Global Efavirenz Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Efavirenz Historic Market Size by Region
  3. 4.2.1 Global Efavirenz Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Efavirenz Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Efavirenz Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Efavirenz Forecasted Market Size by Region
  7. 4.3.1 Global Efavirenz Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Efavirenz Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Efavirenz Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Efavirenz by Application
  1. 5.1 Efavirenz Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Efavirenz Market Size by Application
  5. 5.2.1 Global Efavirenz Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Efavirenz Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Efavirenz Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Efavirenz Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Efavirenz Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Efavirenz Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Efavirenz Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Efavirenz Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Efavirenz Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Efavirenz Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Macleods Pharmaceuticals
  14. 6.3.1 Macleods Pharmaceuticals Company Information
  15. 6.3.2 Macleods Pharmaceuticals Business Overview
  16. 6.3.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Macleods Pharmaceuticals Efavirenz Product Portfolio
  18. 6.3.5 Macleods Pharmaceuticals Recent Developments
  19. 6.4 Hetero
  20. 6.4.1 Hetero Company Information
  21. 6.4.2 Hetero Business Overview
  22. 6.4.3 Hetero Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hetero Efavirenz Product Portfolio
  24. 6.4.5 Hetero Recent Developments
  25. 6.5 Cipla
  26. 6.5.1 Cipla Company Information
  27. 6.5.2 Cipla Business Overview
  28. 6.5.3 Cipla Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cipla Efavirenz Product Portfolio
  30. 6.5.5 Cipla Recent Developments
  31. 6.6 Bristol-Myers Squibb
  32. 6.6.1 Bristol-Myers Squibb Company Information
  33. 6.6.2 Bristol-Myers Squibb Business Overview
  34. 6.6.3 Bristol-Myers Squibb Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Efavirenz Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Efavirenz Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Pharma Efavirenz Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Efavirenz Sales by Country
  2. 7.1.1 North America Efavirenz Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Efavirenz Sales by Country (2021-2026)
  4. 7.1.3 North America Efavirenz Sales Forecast by Country (2027-2032)
  5. 7.2 North America Efavirenz Market Size by Country
  6. 7.2.1 North America Efavirenz Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Efavirenz Market Size by Country (2021-2026)
  8. 7.2.3 North America Efavirenz Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Efavirenz Sales by Country
  2. 8.1.1 Europe Efavirenz Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Efavirenz Sales by Country (2021-2026)
  4. 8.1.3 Europe Efavirenz Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Efavirenz Market Size by Country
  6. 8.2.1 Europe Efavirenz Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Efavirenz Market Size by Country (2021-2026)
  8. 8.2.3 Europe Efavirenz Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Efavirenz Sales by Country
  2. 9.1.1 Asia-Pacific Efavirenz Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Efavirenz Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Efavirenz Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Efavirenz Market Size by Country
  6. 9.2.1 Asia-Pacific Efavirenz Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Efavirenz Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Efavirenz Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Efavirenz Sales by Country
  2. 10.1.1 South America Efavirenz Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Efavirenz Sales by Country (2021-2026)
  4. 10.1.3 South America Efavirenz Sales Forecast by Country (2027-2032)
  5. 10.2 South America Efavirenz Market Size by Country
  6. 10.2.1 South America Efavirenz Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Efavirenz Market Size by Country (2021-2026)
  8. 10.2.3 South America Efavirenz Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Efavirenz Sales by Country
  2. 11.1.1 Middle East and Africa Efavirenz Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Efavirenz Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Efavirenz Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Efavirenz Market Size by Country
  6. 11.2.1 Middle East and Africa Efavirenz Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Efavirenz Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Efavirenz Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Efavirenz Value Chain Analysis
  2. 12.1.1 Efavirenz Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Efavirenz Production Mode & Process
  7. 12.2 Efavirenz Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Efavirenz Distributors
  10. 12.2.3 Efavirenz Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst